UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 287

Sortiert nach

Hepatitis B virus infection

The Lancet (British edition), 2009-02, Vol.373 (9663), p.582-592

2009

Link zum Volltext

Verfügbarkeit prüfen

HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long‐term follow‐up

Hepatology (Baltimore, Md.), 2007-05, Vol.45 (5), p.1187-1192

2007

Link zum Volltext

Verfügbarkeit prüfen

Off‐therapy durability of response to entecavir therapy in hepatitis B e antigen‐negative chronic hepatitis B patients

Hepatology (Baltimore, Md.), 2013-12, Vol.58 (6), p.1888-1896

2013

Link zum Volltext

Verfügbarkeit prüfen

Age‐specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B

Hepatology (Baltimore, Md.), 2010-02, Vol.51 (2), p.435-444

2010

Link zum Volltext

Verfügbarkeit prüfen

Letter to the Editor: Age at Hepatitis B e Antigen Seroconversion and Other Factors for Outcomes of Chronic Hepatitis B

Hepatology (Baltimore, Md.), 2019-06, Vol.69 (6), p.2711-2711

2019

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B surface antigen seroclearance during chronic HBV infection

Antiviral therapy, 2010-01, Vol.15 (2), p.133-143

2010

Link zum Volltext

Verfügbarkeit prüfen

Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase"

Clinical and Molecular Hepatology, 2023, 29(2), , pp.510-512

2023

Link zum Volltext

Verfügbarkeit prüfen

Predictive Factors for Reactivation of Hepatitis B Following Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2007-11, Vol.133 (5), p.1458-1465

2007

Link zum Volltext

Verfügbarkeit prüfen

Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism

Neuropharmacology, 2020-01, Vol.162, p.107736, Article 107736

2020

Link zum Volltext

Verfügbarkeit prüfen

Long‐term outcome of hepatitis B e antigen–negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time

Hepatology (Baltimore, Md.), 2009-06, Vol.49 (6), p.1859-1867

2009

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Risk Factors of Progression to Cirrhosis in Inactive Carriers of Hepatitis B Virus

The American journal of gastroenterology, 2009-07, Vol.104 (7), p.1693-1699

2009

Link zum Volltext

Verfügbarkeit prüfen

Differential mechanisms of synaptic plasticity for susceptibility and resilience to chronic social defeat stress in male mice

Biochemical and biophysical research communications, 2021-07, Vol.562, p.112-118

2021

Link zum Volltext

Verfügbarkeit prüfen

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

Journal of hepatology, 2007-01, Vol.46 (1), p.45-52

2007

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B Virus-Related Cirrhosis: Natural History and Treatment

Seminars in liver disease, 2006-05, Vol.26 (2), p.142-152

2006

Link zum Volltext

Verfügbarkeit prüfen

Decreasing Levels of HBsAg Predict HBsAg Seroclearance in Patients With Inactive Chronic Hepatitis B Virus Infection

Clinical gastroenterology and hepatology, 2012-03, Vol.10 (3), p.297-302

2012

Link zum Volltext

Verfügbarkeit prüfen

A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese

PloS one, 2014-06, Vol.9 (6), p.e99724-e99724

2014

Link zum Volltext

Verfügbarkeit prüfen

Deep Brain Stimulation Modified Autism-Like Deficits via the Serotonin System in a Valproic Acid-Induced Rat Model

International journal of molecular sciences, 2018-09, Vol.19 (9), p.2840

2018

Link zum Volltext

Verfügbarkeit prüfen

Relative Roles of HBsAg Seroclearance and Mortality in the Decline of HBsAg Prevalence With Increasing Age

The American journal of gastroenterology, 2010-05, Vol.105 (5), p.1102-1109

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B

Hepatology (Baltimore, Md.), 2002-06, Vol.35 (6), p.1522-1527

2002

Link zum Volltext

Verfügbarkeit prüfen

Natural history of hepatitis b e antigen to antibody seroconversion in patients with normal serum aminotransferase levels

The American journal of medicine, 2004-06, Vol.116 (12), p.829-834

2004

Link zum Volltext

Verfügbarkeit prüfen

Management of Older Patients With Immunotolerant Chronic Hepatitis B Infection

Clinical gastroenterology and hepatology, 2023-07, Vol.21 (7), p.1968-1969

2023

Link zum Volltext

Verfügbarkeit prüfen

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

Hepatology (Baltimore, Md.), 1999-08, Vol.30 (2), p.567-572

1999

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte expression of hepatitis B surface and core antigens across phases of chronic hepatitis B infection

Journal of hepatology, 2022-11, Vol.77 (5), p.1455-1456

2022

Link zum Volltext

Verfügbarkeit prüfen

Fabrication and Photovoltaic Properties of Dye-Sensitized Solar Cells Modified by Graphene Oxide and Magnetic Bead

IEEE electron device letters, 2015-07, Vol.36 (7), p.711-713

2015

Link zum Volltext
IEEE_Xplore

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection

Gastroenterology (New York, N.Y. 1943), 2002-10, Vol.123 (4), p.1084-1089

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 287

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(254)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hepatitis B virus infection

HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long‐term follow‐up

Off‐therapy durability of response to entecavir therapy in hepatitis B e antigen‐negative chronic hepatitis B patients

Age‐specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B

Letter to the Editor: Age at Hepatitis B e Antigen Seroconversion and Other Factors for Outcomes of Chronic Hepatitis B

Hepatitis B surface antigen seroclearance during chronic HBV infection

Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase"

Predictive Factors for Reactivation of Hepatitis B Following Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B

Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism

Long‐term outcome of hepatitis B e antigen–negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time

Incidence and Risk Factors of Progression to Cirrhosis in Inactive Carriers of Hepatitis B Virus

Differential mechanisms of synaptic plasticity for susceptibility and resilience to chronic social defeat stress in male mice

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

Hepatitis B Virus-Related Cirrhosis: Natural History and Treatment

Decreasing Levels of HBsAg Predict HBsAg Seroclearance in Patients With Inactive Chronic Hepatitis B Virus Infection

A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese

Deep Brain Stimulation Modified Autism-Like Deficits via the Serotonin System in a Valproic Acid-Induced Rat Model

Relative Roles of HBsAg Seroclearance and Mortality in the Decline of HBsAg Prevalence With Increasing Age

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B

Natural history of hepatitis b e antigen to antibody seroconversion in patients with normal serum aminotransferase levels

Management of Older Patients With Immunotolerant Chronic Hepatitis B Infection

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

Hepatocyte expression of hepatitis B surface and core antigens across phases of chronic hepatitis B infection

Fabrication and Photovoltaic Properties of Dye-Sensitized Solar Cells Modified by Graphene Oxide and Magnetic Bead

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection

Suchergebnisse filtern